Back to calendar
Immuneering Corporation (IMRX) Earnings
IMRX reports earnings on Wednesday, August 12, 2026
earnings report
August 12, 2026 · Before Market Open
Q2 2026
Est. EPS: $-0.27
Actual EPS: $-0.21
EPS surprise: 16.67%
Company overview
Market Cap$309.3M
PriceUSD 4.78
EPS (TTM)-1.17
52-week high10.08
52-week low2.90
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees37